Sandra Abrevaya

Sandra Abrevaya's Title

Sandra Abrevaya serves as the Co-Founder and Chief Executive Officer of Synapticure, a company dedicated to providing accessible, compassionate care for patients with neurodegenerative diseases. Her role involves strategic leadership and advocacy, focused on democratizing access to exceptional care and supporting both patients and caregivers.

Sandra Abrevaya's Company

Sandra Abrevaya co-founded Synapticure with Brian Wallach, aiming to improve the lives of individuals affected by neurodegenerative diseases. Synapticure's mission is to offer high-quality, patient-centered care that is both accessible and compassionate. The organization has made significant strides in this area, including the recent announcement of The Michael J. Fox Foundation as an advisor, which aims to enhance specialty care and accelerate Parkinson’s research.

Sandra Abrevaya's Advocacy Work

Sandra Abrevaya is a prominent advocate for better access to care and increased support for caregivers. Through her work with Synapticure, she aims to ensure that patients receive the best possible care regardless of their circumstances. Her advocacy efforts have included visiting the White House to share her story of resilience and push for policy changes that benefit those with neurodegenerative diseases.

Sandra Abrevaya's Documentary Feature

Sandra Abrevaya was featured in the documentary 'No Ordinary Campaign,' which chronicles her and Brian Wallach's journey with ALS. The film highlights their advocacy work and the challenges they face living with the disease. This documentary serves as an important platform for raising awareness about ALS and the need for better healthcare solutions.

Sandra Abrevaya's Personal Journey with ALS

Sandra Abrevaya has been living with ALS for more than six years, an experience that deeply informs her work and advocacy. Her personal journey with the disease adds a profound layer of authenticity and urgency to her efforts to improve care for others facing similar challenges. Her resilience and dedication are evident in her leadership at Synapticure and her ongoing advocacy work.